- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00919997
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
HPV Infection in Indian HIV-Seropositive Men Who Have Sex With Men (MSM)
RATIONALE: Gathering information about human papilloma virus (HPV) infection in HIV-positive men who have sex with men may help doctors learn more about the disease.
PURPOSE: This clinical trial is studying HPV infection in HIV-positive Indian men who have sex with men.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
OBJECTIVES:
- Describe the prevalence of penile, anal, and oral human papilloma virus (HPV) infection in HIV-seropositive Indian men who have sex with men.
- Determine the spectrum of HPV types at these anatomic sites in these patients.
- Determine the distribution of strain variants of HPV 16, 18, and 31 at these anatomic sites in these patients.
- Describe risk factors for penile, anal, and oral HPV infection in these patients.
OUTLINE: This is a multicenter study.
Patients complete interviewer-administered questionnaires on demographics, native place, socioeconomic status, medical history, numbers of sexual partners and sexual practices, circumcision status, and risk factors for oral malignancies and human papilloma virus (HPV), including oral sex, smoking or chewing tobacco, drug use, oral hygiene, and tooth loss.
Patients undergo cell sample collection from the penis, scrotum, anus, and mouth, and saliva sample collection for HPV DNA testing by PCR. Patients also undergo blood sample collection to measure CD4+ count and HIV viral load by FACS and PCR.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
California
-
San Francisco, California, États-Unis, 94115
- UCSF Helen Diller Family Comprehensive Cancer Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
DISEASE CHARACTERISTICS:
HIV-1 infection, as documented by ELISA and confirmed by a second testing method (e.g., western blot, HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA)
- If prior documentation and confirmation of HIV-1 infection is not available, two licensed rapid HIV tests are allowed
- Must have had receptive or insertive anal intercourse with another man within the past 6 months
PATIENT CHARACTERISTICS:
- Speaks Hindi (in Mumbai) or Tamil (in Vellore)
- No active drug or alcohol use or dependence that, in the opinion of the site Investigator, would interfere with adherence to study requirements
- No history of a sex-change operation that would preclude collection of penile or scrotal specimens
PRIOR CONCURRENT THERAPY:
- Not specified
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Specimen collection
Single group study.
Blood, saliva, anal cytology, and penile cytology samples, and questionnaire responses will be collected from participants at a single study visit.
|
Anal pap smear, penile pap smear, blood collection, and saliva collection at a single study visit for HPV DNA analysis.
Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.
Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.
Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.
Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.
Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Detectable human papilloma virus DNA in the penis, anus, or mouth
Délai: Study entry
|
Study entry
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Distribution of strain variants of HPV 16, 18 and 31
Délai: Study entry
|
Study entry
|
Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM
Délai: Study entry
|
Study entry
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Dilip Mathai, MD, Christian Medical College and Hospital
- Chercheur principal: Ashok Row Kavi, Humsafar Trust
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AMC-060
- U01CA121947 (Subvention/contrat des NIH des États-Unis)
- CDR0000629624 (Autre identifiant: NCI)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur DNA analysis
-
Al Baraka Fertility HospitalIbn Sina Hospital; Sadat City UniversityComplétéMaladies génétiques, innées | Mutation | Anomalies chromosomiques
-
Amsterdam UMC, location VUmcDutch Kidney Foundation; B.Braun Avitum AG; Niercentrum aan de AmstelPas encore de recrutementPhase terminale de la maladie rénale
-
Kirby InstituteRetiré
-
Immunomic Therapeutics, Inc.Complété
-
Kirby InstituteRecrutement
-
University of California, San FranciscoNorthern California Institute of Research and Education; Guardant Health,...RecrutementCancer du poumon non à petites cellules | Nodule Solitaire PulmonaireÉtats-Unis
-
Immunomic Therapeutics, Inc.Complété
-
The University of Hong KongInconnueCancer colorectal | Adénome Côlon
-
EuroVacc FoundationCentre Hospitalier Universitaire Vaudois; MRC/UVRI and LSHTM Uganda Research... et autres collaborateursComplété
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United Kingdom; RM Partners...RecrutementFumeur | Alcoolisme | Maladies urologiques | Hypertension | Diabète | Cancer de la prostate | Cancer de la vessie | Cancer du rein | Cancer urologique | Problème de santé mentale | Cancer du testiculeRoyaume-Uni